| Year |
Citation |
Score |
| 2019 |
Eriksson O, Stopa J, Furie B. Identification of PDI Substrates by Mechanism-Based Kinetic Trapping. Methods in Molecular Biology (Clifton, N.J.). 1967: 165-182. PMID 31069770 DOI: 10.1007/978-1-4939-9187-7_10 |
0.731 |
|
| 2019 |
Zwicker JI, Schlechter BL, Stopa JD, Liebman H, Aggarwal A, Puligandla M, Caughey T, Bauer KA, Kuemmerle N, Wong E, Wun T, McLaughlin M, Hidalgo M, Neuberg D, Furie B, et al. Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer. Jci Insight. PMID 30652973 DOI: 10.1172/Jci.Insight.125851 |
0.691 |
|
| 2018 |
Bekendam RH, Iyu D, Passam F, Stopa JD, De Ceunynck K, Muse O, Bendapudi PK, Garnier CL, Gopal S, Crescence L, Chiu J, Furie B, Panicot-Dubois L, Hogg PJ, Dubois C, et al. Protein disulfide isomerase regulation by nitric oxide maintains vascular quiescence and controls thrombus formation. Journal of Thrombosis and Haemostasis : Jth. PMID 30207066 DOI: 10.1111/Jth.14291 |
0.696 |
|
| 2018 |
Stopa JD, Zwicker JI. The intersection of protein disulfide isomerase and cancer associated thrombosis. Thrombosis Research. 164: S130-S135. PMID 29703471 DOI: 10.1016/J.Thromres.2018.01.005 |
0.416 |
|
| 2018 |
Zwicker JI, Schlechter BL, Stopa JD, Liebman HA, Aggarwal A, Caughey T, Bauer KA, Kuemmerle N, Wong EY, Wun T, Mclaughlin M, Puligandla M, Neuberg DS, Furie B, Flaumenhaft RC. Targeting Protein Disulfide Isomerase with the Oral Flavonoid Isoquercetin Prevents Venous Thromboembolism in Advanced Cancer: Results of a Multi-Dose, Multi-Center, Phase II Clinical Trial (CATIQ Study) Blood. 132: 985-985. DOI: 10.1182/Blood-2018-99-114946 |
0.641 |
|
| 2017 |
Stopa JD, Baker KM, Grover SP, Flaumenhaft R, Furie B. Kinetic-based Trapping by Intervening Sequence Variants of the Active Sites of Protein Disulfide Isomerase Identifies Platelet Protein Substrates. The Journal of Biological Chemistry. PMID 28364042 DOI: 10.1074/Jbc.M116.771832 |
0.713 |
|
| 2017 |
Stopa JD, Neuberg D, Puligandla M, Furie B, Flaumenhaft R, Zwicker JI. Protein disulfide isomerase inhibition blocks thrombin generation in humans by interfering with platelet factor V activation. Jci Insight. 2: e89373. PMID 28097231 DOI: 10.1172/Jci.Insight.89373 |
0.697 |
|
| 2016 |
Stopa JD, Neuberg DS, Puligandla M, Furie B, Flaumenhaft RC, Zwicker JI. PDI Inhibition Blocks Thrombin Generation in Humans By Interfering with Platelet Factor V Activation Blood. 128: 2628-2628. DOI: 10.1182/Blood.V128.22.2628.2628 |
0.702 |
|
| 2015 |
Lin L, Gopal S, Sharda A, Passam F, Bowley SR, Stopa J, Xue G, Yuan C, Furie BC, Flaumenhaft R, Huang M, Furie B. Quercetin-3-rutinoside Inhibits Protein Disulfide Isomerase by Binding to Its b'x Domain. The Journal of Biological Chemistry. 290: 23543-52. PMID 26240139 DOI: 10.1074/Jbc.M115.666180 |
0.698 |
|
| 2015 |
Passam FH, Lin L, Gopal S, Stopa JD, Bellido-Martin L, Huang M, Furie BC, Furie B. Both platelet- and endothelial cell-derived ERp5 support thrombus formation in a laser-induced mouse model of thrombosis. Blood. 125: 2276-85. PMID 25624318 DOI: 10.1182/Blood-2013-12-547208 |
0.652 |
|
| 2014 |
Bekendam RH, Srila G, Bendapudi PK, Dilks JR, Lin L, Bowley S, Stopa J, Huang M, Furie B, Croce K, Flaumenhaft R. Regulation of Protein Disulfide Isomerase By S-Nitrosylation Controls Its Function during Thrombus Formation Blood. 124: 93-93. DOI: 10.1182/Blood.V124.21.93.93 |
0.702 |
|
| 2011 |
Stopa JD, Chandani S, Tolan DR. Stabilization of the predominant disease-causing aldolase variant (A149P) with zwitterionic osmolytes. Biochemistry. 50: 663-71. PMID 21166391 DOI: 10.1021/Bi101523X |
0.562 |
|
| 2007 |
Pezza JA, Stopa JD, Brunyak EM, Allen KN, Tolan DR. Thermodynamic analysis shows conformational coupling and dynamics confer substrate specificity in fructose-1,6-bisphosphate aldolase Biochemistry. 46: 13010-13018. PMID 17935305 DOI: 10.1021/Bi700713S |
0.683 |
|
| Show low-probability matches. |